Morosini; Pierfrancesco

Patent Applications and Registrations

Patent applications and USPTO patent grants for Morosini; Pierfrancesco.The latest application filed is for "production of sterile active pharmaceutical ingredients".

Company Profile

0.13.11

Morosini; Pierfrancesco - Milano IT
Morosini; Pierfrancesco - Mapello IT
Morosini; Pierfrancesco - Vilanova del Sillaro IT
Morosini; Pierfrancesco - Villanova del Sillaro IT
Morosini; Pierfrancesco - Lodi IT
Morosini; Pierfrancesco - Milan N/A IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Production Of Sterile Active Pharmaceutical Ingredients App 20210145836 - De Zani; Daniele ; et al.	2021-05-20
Production of sterile active pharmaceutical ingredients Grant 10,953,115 - Leone , et al. March 23, 2	2021-03-23
Process for the preparation of gadobenate dimeglumine complex in a solid form Grant 9,795,695 - Anelli , et al. October 24, 2	2017-10-24
Process for the Preparation of Gadobenate Dimeglumine Complex in a Solid Form App 20160228583 - ANELLI; Pier Lucio ; et al.	2016-08-11
Integrin targeted synthetic ligands for diagnostic and therapeutic applications Grant 9,409,951 - Lattuada , et al. August 9, 2	2016-08-09
Fibrin binding peptide conjugates for diagnostic and therapeutic applications Grant 9,333,272 - Aime , et al. May 10, 2	2016-05-10
Production Of Sterile Active Pharmaceutical Ingredients App 20150141412 - Leone; Mario ; et al.	2015-05-21
Integrin Targeted Synthetic Ligands For Diagnostic And Therapeutic Applications App 20140178302 - LATTUADA; Luciano ; et al.	2014-06-26
Integrin targeted synthetic ligands for diagnostic and therapeutic applications Grant 8,636,977 - Lattuada , et al. January 28, 2	2014-01-28
Contrast agents endowed with high relaxivity Grant 8,540,966 - Aime , et al. September 24, 2	2013-09-24
Contrast agents endowed with high relaxivity App 20110256067 - Aime; Silvio ; et al.	2011-10-20
Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (MRI) which contain a chelating moiety with polyhydroxylated substituents Grant 7,988,950 - Aime , et al. August 2, 2	2011-08-02
Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules App 20110082280 - GIOVENZANA; Giovanni Battista ; et al.	2011-04-07
Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy Grant 7,893,223 - Giovenzana , et al. February 22, 2	2011-02-22
Fibrin Binding Pepetide Conjugates For Diagnostic And Therapeutic Applications App 20100202967 - Aime; Silvio ; et al.	2010-08-12
Integrin Targeted Synthetic Ligands for Diagnostic and Therapeutic Applications App 20080317668 - Lattuada; Luciano ; et al.	2008-12-25
Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents App 20070258905 - Aime; Silvio ; et al.	2007-11-08
Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy App 20060034773 - Giovenzana; Giovanni Battista ; et al.	2006-02-16
Paramagnetic metal icon chelates and use thereof as contrast agents in magnetic resonance imaging Grant 5,649,537 - Anelli , et al. July 22, 1	1997-07-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.